StoryTechnical·AI & ScienceHighThu, Mar 19, 4:00 AM
AI Drug Discovery Is Having a Week. The Field's Credibility Problem Is Having a Decade.
Boltz-2, a Harvard gene-drug tool, an AstraZeneca molecular modeling push, and a $95M Series A all dropped within days of each other. The science may be real. The pattern looks like something else.